Europe Artificial Intelligence In Cancer Diagnostics Market Size & Outlook
Related Markets
Europe artificial intelligence in cancer diagnostics market highlights
- The Europe artificial intelligence in cancer diagnostics market generated a revenue of USD 37.8 million in 2023.
- The market is expected to grow at a CAGR of 27.7% from 2024 to 2030.
- In terms of segment, software was the largest revenue generating component type in 2023.
- Services is the most lucrative component type segment registering the fastest growth during the forecast period.
- Country-wise, Germany is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 37.8 million |
| Market revenue in 2030 | USD 208.9 million |
| Growth rate | 27.7% (CAGR from 2023 to 2030) |
| Largest segment | Software |
| Fastest growing segment | Services |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Software, Hardware, Services |
| Key market players worldwide | Microsoft Corp, Roche Holding AG, Quest Diagnostics Inc, Medial EarlySign, CancerCenter.AI, Therapixel, Tempus, Kheiron, SkinVision |
Other key industry trends
- In terms of revenue, Europe region accounted for 19.5% of the global artificial intelligence in cancer diagnostics market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 247.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Artificial Intelligence In Cancer Diagnostics Market Scope
Artificial Intelligence In Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| SkinVision | View profile | 11-50 | Amsterdam, Noord-Holland, The Netherlands, Europe | https://skinvision.com |
| Kheiron | View profile | 11-50 | London, England, United Kingdom, Europe | https://www.kheironmed.com/ |
| Tempus | View profile | 501-1000 | Chicago, Illinois, United States, North America | https://www.tempus.com |
| Therapixel | View profile | 11-50 | Nice, Provence-Alpes-Cote d'Azur, France, Europe | http://www.therapixel.com/ |
| CancerCenter.AI | View profile | 11-50 | Wroclaw, Dolnoslaskie, Poland, Europe | https://cancercenter.ai |
| Medial EarlySign | View profile | 11-50 | Hod Hasharon, HaMerkaz, Israel, Asia | http://earlysign.com/ |
| Quest Diagnostics Inc | View profile | 48000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | https://www.questdiagnostics.com |
| Roche Holding AG | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Microsoft Corp | View profile | 221000 | One Microsoft Way, Redmond, WA, United States, 98052-6399 | https://www.microsoft.com |
Europe artificial intelligence in cancer diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in cancer diagnostics market will help companies and investors design strategic landscapes.
Software was the largest segment with a revenue share of 47.88% in 2024. Horizon Databook has segmented the Europe artificial intelligence in cancer diagnostics market based on software, hardware, services covering the revenue growth of each sub-segment from 2018 to 2030.
Healthcare systems in Europe are overburdened due to increasing costs, rising incidence of cancer cases, increasing demand for healthcare facilities, and stagnating or shrinking healthcare workforce. The industry also faces issues due to structural inefficiencies in certain European countries. The move to value-based healthcare is expected to strengthen patient outcomes at a more sustainable cost.
Incorporating AI into innovative medical technologies can help address the pressing healthcare issues. In addition, increasing investments in AI in healthcare are driving the market growth. For instance, in October 2019, the UK government announced an investment of USD 300 billion in AI, which is expected to be utilized by the public healthcare system to improve the quality of care.
Many AI applications are already in operation or awaiting deployment, which can contribute to earlier cancer detection, more accurate diagnosis, identification of new observations or patterns in human physiology, and development of personalized diagnostics & therapeutics.
Reasons to subscribe to Europe artificial intelligence in cancer diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe artificial intelligence in cancer diagnostics market databook
-
Our clientele includes a mix of artificial intelligence in cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe artificial intelligence in cancer diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe artificial intelligence in cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe artificial intelligence in cancer diagnostics market size, by country, 2018-2030 (US$M)
Europe Artificial Intelligence In Cancer Diagnostics Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
